Medical Device News Magazine

Access Vascular Announces Outcome of a Peer-reviewed Study Published in the Journal of Infusion Nursing

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • The findings of this study indicate the potential for catheters made from AVI’s patented advanced biomaterials to reduce the frequency of device replacements and avoid these complications – improving patient outcomes, saving time for clinicians and helping hospitals avoid the high cost of vascular access and related complications.

Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications through its advanced biomaterial platform, today announced the outcome of a peer-reviewed study published in the Journal of Infusion Nursing that demonstrated a significant reduction in complications when using AVI’s consistently hydrophilic midline catheters.

Common and expensive complications affect approximately 30% of all hospital patients with traditional polyurethane catheters inserted. The findings of this study indicate the potential for catheters made from AVI’s patented advanced biomaterials to reduce the frequency of device replacements and avoid these complications – improving patient outcomes, saving time for clinicians and helping hospitals avoid the high cost of vascular access and related complications.

In the paper, A Retrospective Assessment of Midline Catheter Failures Focusing on Catheter Composition, complication rates are compared in 101 standard midline catheters and 104 HydroMID® catheters. The data analysis indicates statistically significant reductions in failure rates, upper extremity deep venous thrombosis, and phlebitis in the HydroMID group, with the polyurethane midline catheters six (6) times more likely to fail then HydroMID catheters.

“I have inserted over 2000 catheters with this patented biomaterial and I’m pleased to see the findings of this study support what I’ve seen in my daily experience,” said Joe Bunch, RN, CEO of ProVasc Solutions LTD, and principal investigator for the study. “The reduction in complications makes a dramatic impact on both my patients and my workflow with a significant decrease in call backs to trouble shoot the lines.”

Access Vascular’s HydroPICC® and HydroMID® catheters are made from an entirely new catheter material designed to work in concert with the body’s natural chemistry, thus helping to reduce both complications and associated medical expense. The transformational AVI technology was most recently recognized with a 2022 Edison Award for Innovation for its potential to reshape the field of vascular access.

“We are thrilled that these study findings have been published and confirm what we’ve seen and what our clinicians have been telling us – the AVI hydrophilic biomaterial substantially lowers complications and device replacements. The impact of this reduction is giving back critical clinician time and providing hospital cost savings, which – in the end – brings down total medical expenses,” said James Biggins, CEO of Access Vascular. “Our transformational technology is helping to usher in the new era of value-based care by improving the patient experience and supporting an overall reduction in medical costs. I would encourage any clinician or hospital frustrated with the performance of their current lines to work with our team to incorporate our technology into their practice.”

To learn more about Access Vascular and its HydroPICC and HydroMID products, please visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.